Tanimura F
Department of Otolaryngology, Municipal Yamashiro Hospital, Kyoto, Japan.
Arch Otorhinolaryngol. 1989;246(2):79-82. doi: 10.1007/BF00457458.
Lipid A is a covalently bound component of gram-negative bacterial lipopolysaccharides and is the biologically active component in endotoxin. In order to detect and quantitate lipid A in middle ear effusions (MEE) from patients with otitis media with effusion (OME), antisera against lipid A were produced in mice by repeated immunization with conjugates using lipid A from Salmonella minnesota Re595 and bovine serum albumin. As a result, a competitive enzyme-linked immunosorbent assay (ELISA) was developed that was specific for lipid A. From the ELISA results, 10 out of 15 samples from the serous type MEE (mean, 13.57 +/- 2.17 micrograms/ml) and 5 out of 6 from the mucoid type MEE (17.73 +/- 4.34 micrograms/ml) were positive. These findings indicate that lipid A may contribute to the pathogenesis of both types of human OME.
脂多糖A是革兰氏阴性菌脂多糖的共价结合成分,是内毒素中的生物活性成分。为了检测和定量来自分泌性中耳炎(OME)患者中耳积液(MEE)中的脂多糖A,通过用来自明尼苏达沙门氏菌Re595的脂多糖A与牛血清白蛋白的偶联物对小鼠进行反复免疫,制备了抗脂多糖A的抗血清。结果,开发了一种对脂多糖A具有特异性的竞争性酶联免疫吸附测定(ELISA)。根据ELISA结果,浆液性MEE的15个样本中有10个(平均值为13.57 +/- 2.17微克/毫升)呈阳性,粘液性MEE的6个样本中有5个(17.73 +/- 4.34微克/毫升)呈阳性。这些发现表明脂多糖A可能在两种类型的人类OME发病机制中起作用。